ArticleEuropean journal of medicinal chemistry2026

Novel PROTACs targeting tissue transglutaminase (TG2) suppress tumorigenicity of ovarian cancer cells.

Andres Valdivia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.